Navigation Links
Samaritan Partners 'Forgetful' Rat Model to Taconic to Commercialize
Date:10/1/2008

The Samaritan Alzheimer's Rat Model

- Mimics Human Alzheimer's

- Speeds 'Race for Time' to Find Cure

- Saves Valuable Research Money

LAS VEGAS, Oct. 1 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals (OTC Bulletin Board: SPHC) (http://www.samaritanpharma.com) and Taconic Farms, Hudson, New York, are pleased to announce they have inked a worldwide partnering agreement to commercialize "The Samaritan Alzheimer's Rat Model." The "forgetful" rat model is a research tool used by scientists to study the effectiveness of their new drugs to treat Alzheimer's disease. The unique benefits of the rat model lie in its ability,

-- To mimic many features of human Alzheimer's including memory loss,

-- Speed a scientist's "race for time" in finding a cure for the

mind-robbing disease

-- Save scientists valuable research money.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/LAW054)

The rat model is now available exclusively through Taconic. Samaritan will receive royalties on net sales. Financial terms were not disclosed.

"Taconic is extremely pleased to offer researchers a new and potentially invaluable weapon in the war on neurodegenerative disease," said Todd Little, President of Taconic. "The rapid time to disease state of the Samaritan Alzheimer's Rat Model will enable investigators to conduct Alzheimer's drug target screening on a much faster timeline than ever before."

The rat model is published in Pharmacology, 2006;76:19-33

"Taconic provides us with an experienced partner to monetize this unique animal model to 'rat out' Alzheimer's. The rat model is groundbreaking, in that it offers significant advantages over other options previously available for the s
'/>"/>

SOURCE Samaritan Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. Riverside Partners Sells MicroCal to GE Healthcare
3. onTargetjobs and ClearedConnections Announce Online Recruitment Partnership
4. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
5. Satyam Partners with Oracle to Provide Clinical Development Applications
6. alli(TM) Partners with Breast Cancer Network of Strength(TM) to Support Women Challenged by Breast Cancer, Weight Loss or Both
7. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
8. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
11. NIST and partners identify tiny gold clusters as top-notch catalysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... YORK , May 21, 2015  Susan ... Research (FPWR), a nonprofit organization dedicated to supporting ... Prader-Willi syndrome (PWS), announced today that FPWR has ... and Irina Shaulov contributed $1 million ... clinical initiatives.  ...
(Date:5/21/2015)... Germany (PRWEB) May 21, 2015 ... that its manufacturing facility in Worms, Germany has ... an independent subsidiary of the International Pharmaceutical Excipient ... Grace facilities that produce its SYLOID® FP brand ... received GMP certification, following the Curtis Bay, Maryland ...
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
... CALL DATE: Wednesday, Aug. 6, 2008 TIME: ... Dr. Candace Kendle, Chairman and CEO, ... call and,simultaneous webcast on Wednesday, Aug. 6 at 9:30 a.m. Eastern ... 30, 2008. A,question and answer session will follow., Webcast Instructions, ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced ... Daiichi Sankyo), has received marketing,approval from the Japanese ... label extension of Biopten(R) (sapropterin dihydrochloride), which,contains the ... for the,treatment of patients with phenylketonuria (PKU). BioMarin ...
... Consent Judgment Terminating Litigation --, MADISON, N.J., ... and,Impax Laboratories Inc. today announced that all conditions ... pertaining to Impax,s proposed,generic capsule formulation of Wyeth,s ... States District Court for the District of,Delaware. The ...
Cached Biology Technology:Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast 2Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 2Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 3Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 4Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit 2Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit 3
(Date:4/10/2015)... 2015 Research and Markets ( ... "Security Competitive Profiles - NEC" report to their ... NEC will continue to supply a range of IT ... a company focus on the development of a Big ... opportunities in the Asia-Pacific region ...
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/143028 for MINIATURE, ... ENERGY TRANSFER  NXT-ID introduces a new ... This patent surrounds the use of miniature antenna ...
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... by a combination of genetic and environmental factors. For ... external influences. According to scientists from the Max Planck ... not harmful bacteria that trigger multiple sclerosis, but ... every human being needs for digestion. The researchers ...
... -- On Friday, Oct. 28 2011 the research icebreaker ... 200 scientists and technicians from research institutions in 14 ... They will examine a wide variety of topics: oceanography ... bacteria, tiny algae and animals all the way to ...
... DIEGO (Oct.27, 2011) The La Jolla ... fifth organization in the prestigious Sanford Consortium for ... for Biological Studies, The Scripps Research Institute, University ... Research Institute in the first-of-its-kind multi-institutional stem cell ...
Cached Biology News:Natural intestinal flora involved in the emergence of multiple sclerosis 2Natural intestinal flora involved in the emergence of multiple sclerosis 3RV Polarstern launches 28th Antarctic season 2La Jolla Institute joins Sanford Consortium for Regenerative Medicine 2La Jolla Institute joins Sanford Consortium for Regenerative Medicine 3
Request Info...
... are available in two product models - the ... models is that the 6000AT+ includes a membrane ... aerosol for improved detection limits and reduced oxides. ... range of elements by 10-40 times. Note that ...
... of RNase A-type ribonucleases Product Description: ,QIAGEN ... origin that binds noncovalently and inactivates a ... and C). It does not interfere with ... CL3. QIAGEN RNase Inhibitor inhibits greater than ...
... Radiolabeled Ligands\n\nReceptor-related research has long been enabled ... ligands selected to keep pace with new ... products and services for receptor research and ... If you do not find exactly what ...
Biology Products: